PURPOSE: To analyze prognostic factors and long-term outcomes in patients with locally recurrent pelvic cancer (LRPC) treated with a multidisciplinary approach. METHODS AND MATERIALS: From January 1995 to December 2011, 81 patients [rectal (47 %); gynecologic (39 %); retroperitoneal sarcoma (14 %)] underwent extended surgery [multiorgan (58 %), bone (35 %), vascular (9 %), soft tissue (63 %)] and intraoperative electron beam radiation therapy (IOERT) to treat recurrent tumors in the pelvic region. Thirty-five patients (43 %) received external beam radiotherapy (EBRT). Survival was estimated using the Kaplan-Meier method, and risk factors were identified using univariate and multivariate analysis. RESULTS: Median follow-up was 39 months (6-189 months); the 1- 3- and 5-year rates of locoregional control (LRC) were 83, 53, and 41 %, respectively. Univariate Cox proportional hazard analysis revealed worse LRC in patients who did not receive integrated EBRT as rescue treatment of pelvic recurrence (p = 0.003) or underwent non-radical resection (p = 0.01). In the multivariate analysis EBRT, non-radical resection, and tumor fragmentation retained significance (p = 0.002, p = 0.004, and p = 0.05, respectively). CONCLUSIONS: Radical resection, absence of tumor fragmentation and addition of EBRT for rescue are associated with improved LRC in patients with LRPC. Our results suggest that this group can benefit from EBRT combined with extended surgical resection and IOERT.
PURPOSE: To analyze prognostic factors and long-term outcomes in patients with locally recurrent pelvic cancer (LRPC) treated with a multidisciplinary approach. METHODS AND MATERIALS: From January 1995 to December 2011, 81 patients [rectal (47 %); gynecologic (39 %); retroperitoneal sarcoma (14 %)] underwent extended surgery [multiorgan (58 %), bone (35 %), vascular (9 %), soft tissue (63 %)] and intraoperative electron beam radiation therapy (IOERT) to treat recurrent tumors in the pelvic region. Thirty-five patients (43 %) received external beam radiotherapy (EBRT). Survival was estimated using the Kaplan-Meier method, and risk factors were identified using univariate and multivariate analysis. RESULTS: Median follow-up was 39 months (6-189 months); the 1- 3- and 5-year rates of locoregional control (LRC) were 83, 53, and 41 %, respectively. Univariate Cox proportional hazard analysis revealed worse LRC in patients who did not receive integrated EBRT as rescue treatment of pelvic recurrence (p = 0.003) or underwent non-radical resection (p = 0.01). In the multivariate analysis EBRT, non-radical resection, and tumor fragmentation retained significance (p = 0.002, p = 0.004, and p = 0.05, respectively). CONCLUSIONS: Radical resection, absence of tumor fragmentation and addition of EBRT for rescue are associated with improved LRC in patients with LRPC. Our results suggest that this group can benefit from EBRT combined with extended surgical resection and IOERT.
Authors: Sean C Dowdy; Andrea Mariani; William A Cliby; Michael G Haddock; Ivy A Petersen; Franklin H Sim; Karl C Podratz Journal: Gynecol Oncol Date: 2006-05 Impact factor: 5.482
Authors: Fabio Pacelli; Antonio P Tortorelli; Fausto Rosa; Maurizio Bossola; Alejandro M Sanchez; Valerio Papa; Vincenzo Valentini; Giovanni B Doglietto Journal: Ann Surg Oncol Date: 2009-10-16 Impact factor: 5.344
Authors: Phuoc T Tran; Wendy Hara; Zheng Su; H Jill Lin; Pavan K Bendapudi; Jeffrey Norton; Nelson Teng; Christopher R King; Daniel S Kapp Journal: Int J Radiat Oncol Biol Phys Date: 2008-04-18 Impact factor: 7.038
Authors: C V Sole; F A Calvo; M A Lozano; L Gonzalez-Bayon; C Gonzalez-Sansegundo; A Alvarez; S Lizarraga; J L García-Sabrido Journal: Strahlenther Onkol Date: 2013-12-06 Impact factor: 3.621
Authors: Felipe A Calvo; Claudio V Sole; Pedro Alvarez de Sierra; Marina Gómez-Espí; Jose Blanco; Miguel A Lozano; Emilio Del Valle; Marcos Rodriguez; Alberto Muñoz-Calero; Fernando Turégano; Rafael Herranz; Luis Gonzalez-Bayon; Jose Luis García-Sabrido Journal: Int J Radiat Oncol Biol Phys Date: 2013-08-01 Impact factor: 7.038
Authors: R Martínez Monge; M Jurado; I Azinovic; J J Aristu; E Tangco; J C Viera; J M Berián; F A Calvo Journal: Radiother Oncol Date: 1993-08 Impact factor: 6.280
Authors: Raphaëla C Dresen; Marleen J Gosens; Hendrik Martijn; Grard A Nieuwenhuijzen; Geert-Jan Creemers; Alette W Daniels-Gooszen; Adriaan J van den Brule; Hetty A van den Berg; Harm J Rutten Journal: Ann Surg Oncol Date: 2008-04-04 Impact factor: 5.344
Authors: Claudio V Sole; Felipe A Calvo; Carlos Ferrer; Javier Pascau; Hugo Marsiglia Journal: Strahlenther Onkol Date: 2014-06-14 Impact factor: 3.621